PARLIAMENTARY WRITTEN QUESTION
Zimbabwe: HIV Infection (22 November 2022)

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what support the Government is providing the World Health Organisation for injectable cabotegravir (CAB-LA) programmes (a) generally and (b) to support HIV/Aids treatment and prevention in Zimbabwe.

Asked by:
Navendu Mishra (Labour)

The UK is a long-standing supporter of the World Health Organization (WHO) and one of its largest donors, with a focus on supporting WHO to reform and to address UK global health priorities including, but not limited to, achieving universal health coverage, improving global health security, and better pandemic preparedness and response. WHO has published specific guidance (https://www.who.int/publications/i/item/9789240054097) on offering injectable cabotegravir (CAB-LA) as an HIV prevention tool, and will support partners and countries, including Zimbabwe, to include CAB-LA safely and effectively in HIV prevention programmes and advance regulatory approval.

Answered by:
Mr Andrew Mitchell (Conservative)
30 November 2022